Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma

被引：23
|
作者：
Young, Kate [1 ]
Smyth, Elizabeth [1 ]
Chau, Ian [1 ]
机构：
[1] Royal Marsden Hosp, Gastrointestinal Oncol Unit, Sutton SM2 5PT, Surrey, England
来源：
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2015年 / 8卷 / 06期
关键词：
angiogenesis; gastric cancer; gastro-oesophageal cancer; ramucirumab; vascular endothelial growth factor; vascular endothelial growth factor receptor 2; RANDOMIZED PHASE-III; 2ND-LINE CHEMOTHERAPY; 1ST-LINE THERAPY; SUPPORTIVE CARE; DOUBLE-BLIND; OPEN-LABEL; GROWTH; COMBINATION; PLUS; VEGF;
D O I：
10.1177/1756283X15592586
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Ramucirumab, a fully humanized monoclonal antibody directed against vascular endothelial growth factor receptor 2, is the first targeted agent to have demonstrated an improvement in survival, as a single agent or in combination, in a molecularly unselected population in gastro-oesophageal cancer. Now that second-line treatment is routinely considered for patients with advanced gastro-oesophageal cancer, ramucirumab, with its favourable toxicity profile compared with cytotoxic treatment, provides a valuable additional treatment option.
引用
收藏
页码：373 / 383
页数：11
相关论文
共 50 条
  • [21] Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer
    Okines, Alicia F. C.
    Cunningham, David
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (05): : 301 - 318
  • [22] Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population
    Abbas, M. Nazim
    Bright, Tim
    Price, Timothy
    Karapetis, Christos
    Thompson, Sarah
    Connell, Caroline
    Watson, David
    Barnes, Mary
    Bull, Jeff
    Singhal, Nimit
    Roy, Amitesh
    ANZ JOURNAL OF SURGERY, 2021, 91 (12) : 2675 - 2682
  • [23] Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma
    Zeng, Hanqing
    Wang, Chunjiang
    Song, Li-Ying
    Jia, Su-Jie
    Zeng, Xiaohui
    Liu, Qiao
    BMJ OPEN, 2022, 12 (11):
  • [24] Efficacy and Safety of Ramucirumab/nab-paclitaxel for Previously Treated Advanced Gastric Cancer in Community Hospitals
    Hashida, Shinsuke
    Tanaka, Norimitsu
    Takahashi, Yuta
    Onoda, Yuji
    Colvin, Hugh Shunsuke
    Ohashi, Ryuichiro
    Okamoto, Kunio
    ACTA MEDICA OKAYAMA, 2021, 75 (02) : 133 - 138
  • [25] A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma
    Scott, L. C.
    Yao, J. C.
    Benson, A. B., III
    Thomas, A. L.
    Falk, S.
    Mena, R. R.
    Picus, J.
    Wright, J.
    Mulcahy, M. F.
    Ajani, J. A.
    Evans, T. R. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 363 - 370
  • [26] Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
    Clements, Hollie A.
    Underwood, Tim J.
    Petty, Russell D.
    BRITISH JOURNAL OF CANCER, 2024, 130 (01) : 9 - 18
  • [27] Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab Monotherapy
    Watanabe, Hayato
    Yamada, Takanobu
    Komori, Keisuke
    Hara, Kentaro
    Kano, Kazuki
    Takahashi, Kosuke
    Kumazu, Yuta
    Fujikawa, Hirohito
    Numata, Masakatsu
    Aoyama, Toru
    Tamagawa, Hiroshi
    Inokuchi, Yasuhiro
    Machida, Nozomu
    Shiozawa, Manabu
    Yukawa, Norio
    Morinaga, Soichiro
    Rino, Yasushi
    Masuda, Munetaka
    Ogata, Takashi
    Oshima, Takashi
    IN VIVO, 2021, 35 (01): : 563 - 569
  • [28] Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer
    Wagner, Anna D.
    Lordick, Florian
    Grabsch, Heike, I
    Terashima, Masanori
    Terada, Mitsumi
    Yoshikawa, Takaki
    Boku, Narikazu
    Kataoka, Kozo
    Smyth, Elizabeth C.
    Mauer, Murielle
    Haustermans, Karin
    Moehler, Markus H.
    EUROPEAN JOURNAL OF CANCER, 2020, 124 : 67 - 76
  • [29] Ramucirumab for the treatment of gastric adenocarcinoma
    Vassilakopoulou, Maria
    Harada, Kazuto
    Ajani, Jaffer A.
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (08): : 449 - 455
  • [30] Adenocarcinoma of the gastro-oesophageal junction after sleeve gastrectomy: a case report
    Sohn, Sangsu
    Fischer, Jesse
    Booth, Michael
    ANZ JOURNAL OF SURGERY, 2017, 87 (10) : E163 - E164
12345